Cargando...
Emerging therapies for acute myeloid leukemia
Acute myeloid leukemia (AML) is characterized by clinical and biological heterogeneity. Despite the advances in our understanding of its pathobiology, the chemotherapy-directed management has remained largely unchanged in the past 40 years. However, various novel agents have demonstrated clinical ac...
Guardado en:
| Publicado en: | J Hematol Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5395764/ https://ncbi.nlm.nih.gov/pubmed/28420416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0463-6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|